No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BEN240719C22500
- 0.35
- -0.05-12.50%
15min DelayClose Jul 1 16:00 ET
0.35High0.35Low
0.35Open0.40Pre Close8 Volume5.85K Open Interest22.50Strike Price280.00Turnover23.55%IV3.25%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.35Extrinsic Value100Contract SizeAmericanOptions Type0.4044Delta0.3351Gamma68.09Leverage Ratio-0.0139Theta0.0042Rho27.54Eff Leverage0.0190Vega
Intraday
- 5D
- Daily
News
Franklin Resources Files Shelf Registration for Sale of Shares by Stockholder
Express News | Franklin Resources Inc Files for Offering of up to 31.6 Mln Shares by the Selling Stockholder - SEC Filing
GL, SYF Among Top S&P 500 Financial Movers in Q2
Market Chatter: SEC Could Approve Spot Price Ether ETFs by July 4
Franklin Resources To Go Ex-Dividend On June 28th, 2024 With 0.31 USD Dividend Per Share
Franklin Templeton Launches Suite of Tax-Managed Active and Passive SMAs at UBS, Powered by Canvas Custom Indexing Solution
Comments
Morning mooers! It is Monday, April 29th, and the market is open and chugging away on most recent earnings. This week is the most jam packed earnings week so far, with 175 firms in the S&P 500 reporting.
My name is Kevin Travers, and I am writing this update from the Nasdaq offices in Times Square, where moomooo is holding a partnership event! Tune in to the live tab to see the presentations and KOL features.
Here are your morning moovers:...
My name is Kevin Travers, and I am writing this update from the Nasdaq offices in Times Square, where moomooo is holding a partnership event! Tune in to the live tab to see the presentations and KOL features.
Here are your morning moovers:...
14
$Amylyx Pharmaceuticals(AMLX.US$
I have no doubt in Franklin, especially when both are together in one stock![]()
. I think both $Franklin Resources(BEN.US$ and $Franklin Biotechnology Discovery Fund(LU0109394709.MF$ are here. I don't know the second one could not link to AMLX.US, is it his holding company?
Relyvrio is approved in the US, Albrioza in Canada. AKA Phoenix.
Pegasus (Phase 2) is in there for Alzheimer. Helios (Phase 2) for Wolfram Syndrome and Orion (P...
I have no doubt in Franklin, especially when both are together in one stock
Relyvrio is approved in the US, Albrioza in Canada. AKA Phoenix.
Pegasus (Phase 2) is in there for Alzheimer. Helios (Phase 2) for Wolfram Syndrome and Orion (P...
2
Insider selling, especially the large scale by Alok Sethi and lack of buying in past year, creates concern despite high level of insider ownership. The sale above the current share price does not reveal insider sentiment about company value.
Franklin Templeton eyes significant growth in Canada, expecting Andrew Ashton's expertise to fuel expansion. The potential acquisition of Putnam Investments may unlock new opportunities.
Market overreactions and irrational behavior of investors may lead to discrepancies between a company's fundamentals and its stock performance. The drop in Franklin Resources' stock may be due to past unreasonable growth expectations or a potential one-off gain or loss that is ignored.
Read more